Vanda Pharmaceuticals Inc. Balance Sheet
VNDA|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Vanda Pharmaceuticals Inc. had $489M in total assets and $539M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $84.9M | $102.3M | $135.8M | $135.0M | $52.1M | $61.0M | $45.1M | $61.0M | $33.6M | $60.9M | $64.8M | $88.8M | $87.9M | $42.6M | $205.3M |
| Accounts Receivable | $54.6M | $47.1M | $34.2M | $33.5M | $32.5M | $30.0M | $26.4M | $28.8M | $17.6M | $20.3M | $16.3M | $3.7M | $2.0M | $1.2M | $1.6M |
| Inventory | $1.9M | $1.7M | $1.4M | $1.2M | $1.0M | $1.3M | $1.1M | $994.0K | $840.0K | $779.0K | $1.3M | $5.2M | - | $57.0K | - |
| Current Assets | $347.3M | $438.9M | $432.9M | $519.3M | $478.3M | $409.1M | $354.1M | $299.1M | $169.9M | $174.2M | $166.5M | $141.7M | $135.6M | $126.0M | $153.5M |
| PP&E (Net) | $2.2M | $2.1M | $2.0M | $2.6M | $3.1M | $4.1M | $3.9M | $4.4M | $5.3M | $5.0M | $4.6M | $2.4M | $2.2M | $2.3M | $964.0K |
| Total Assets | $488.9M | $656.2M | $648.4M | $634.2M | $593.8M | $533.5M | $483.7M | $332.1M | $205.4M | $210.4M | $213.1M | $171.7M | $143.3M | $135.4M | $182.6M |
| Current Liabilities | $145.2M | $100.0M | $87.7M | $91.4M | $74.4M | $65.9M | $59.5M | $53.0M | $70.4M | $50.3M | $51.3M | $7.8M | $32.9M | $32.3M | $31.6M |
| Shareholders' Equity | $538.5M | $527.2M | $504.9M | $453.3M | $410.9M | $275.4M | $131.4M | $131.3M | $133.0M | $160.8M | $44.1M | $9.9M | $33.5M | $37.7M | $23.0M |